Inventor
MENET CHRISTEL JEANNE MARIE
BE30 patents
⚠️ This page may combine multiple inventors who share the name “MENET CHRISTEL JEANNE MARIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MENET CHRISTEL JEANNE MARIE
13 patentsUS8563545B2Oct 22, 2013
Compound useful for the treatment of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE28 citations95
US8088764B2Jan 3, 2012
Compound useful for the treatment of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE34 citations95
US9707237B2Jul 18, 2017
Compound useful for the treatment of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE16 citations92
US8242274B2Aug 14, 2012
Triazolopyridine kinase inhibitors useful for the treatment of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE18 citations91
US9415037B2Aug 16, 2016
Compounds useful for the treatment of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE15 citations90
US8853240B2Oct 7, 2014
Compounds useful for the treatment of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE16 citations90
US9505754B2Nov 29, 2016
Compound useful for the treatment of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE9 citations82
US9241931B2Jan 26, 2016
Compound useful for the treatment of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE1 citations60
US8975406B2Mar 10, 2015
Compound useful for the treatment of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE1 citations60
US8802682B2Aug 12, 2014
Compound useful for the treatment of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE1 citations60
US8796457B2Aug 5, 2014
Compound useful for the treatment of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE0 citations51
US9987272B2Jun 5, 2018
Compound useful for the treatement of degenerative and inflammatory diseases
MENET CHRISTEL JEANNE MARIE0 citations49
US10179771B2Jan 15, 2019
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
MENET CHRISTEL JEANNE MARIE0 citations45
GALAPAGOS NV
10 patentsUS10328081B2Jun 25, 2019
Compound useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV9 citations92
US9309244B2Apr 12, 2016
Compound useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV14 citations92
US8999979B2Apr 7, 2015
Compound useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV15 citations92
US11000528B2May 11, 2021
Compound useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV7 citations83
US10206907B2Feb 19, 2019
Compounds useful for the treatment of degenerative and inflammatory diseases
GALAPAGOS NV4 citations82
US9382254B2Jul 5, 2016
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV2 citations57
US9440929B2Sep 13, 2016
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV2 citations56
US10568879B2Feb 25, 2020
Dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV1 citations54
US9867806B2Jan 16, 2018
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
GALAPAGOS NV0 citations47
US10508111B2Dec 17, 2019
6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors
GALAPAGOS NV0 citations34
ABBVIE SARL
4 patentsUS10259810B2Apr 16, 2019
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL5 citations82
US9890158B2Feb 13, 2018
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL5 citations81
US10647717B2May 12, 2020
N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL1 citations71
US10130622B2Nov 20, 2018
Compounds for treatment of cystic fibrosis
ABBVIE SARL0 citations37